5. bis 9. Mai 2012, Florenz
15th International and 14th European Congress of Endocrinology
Einzelheiten finden Sie unter www.ice-ece2012.com
Vorschau auf das wissenschaftliche Programm (Stand Novenber 2010)
Download preliminary programme brochure (pdf) (10.11mb)
| 5 May 2012 | |||
| 08:00 17:00 | Pre-Congress Course: Proper Medical Writing For the full programme and to register for your place on this course, please visit the Medical Writing Course section on this website by clicking on the session title above. | ||
| 09:00 17:00 | Pre-Congress Course: Thyroid Ultrasound For the full programme and to register for your place on this course, please visit the Thyroid Ultrasound Course section on this website by clicking on the session title above. | ||
| 12:00 20:00 | Registration Registration | ||
| 15:00 17:00 | Pre-Congress Industry Sponsored Satellite Symposia | ||
| 17:30 17:55 | ICE/ECE 2012 Opening Ceremony: Welcome & Introduction Main Lecture Hall Chairs: F. Casanueva, ISE President (Spain) & P. Bouchard, ESE President (France) | ||
| 17:30 | Welcome to Florence & ICE/ECE 2012 M. Reincke, POC Chair (Germany) & G. Forti, LOC Chair (Italy), | ||
| 17:35 | ISE Presidential Address F. Casanueva, (Spain) | ||
| 17:45 | ESE Presidential Address P. Bouchard, (France) | ||
| 17:55 18:40 | Opening Ceremony: Geoffrey Harris Prize Lecture Main Lecture Hall Chair: B. Jarzab (Poland) | ||
| 17:55 | GH1
GH1
| Glucocorticoid metabolism and the brain, from fetal programming to senescence J. Seckl, (UK) | |
| 18:45 19:30 | Opening Ceremony: European Journal of Endocrinology Prize Lecture Main Lecture Hall Chair: H. Romijn - Editor-in-Chief of EJE (The Netherlands) | ||
| 19:30 21:00 | ICE/ECE 2012 Welcome Reception Exhibition Hall | ||
| 6 May 2012 | |||
| 07:00 20:00 | Registration | ||
| 07:00 08:30 | Industry Sponsored Satellite Symposia | ||
| 08:30 09:15 | Plenary Lecture 1 | ||
| 08:30 | PL1
PL1
| Red Wine Endocrinology D. Sinclair, (USA) | |
| 09:30 11:00 | Symposium 1: Molecular mechanisms of differentiated thyroid cancer Chairs: R. Elisei (Italy & B. Jarzab (Poland) | ||
| 09:30 | S1.1
S1.1
| Molecular consequences of deregulated microRNAs in papilliary thyroid carcinoma A. de la Chapelle, (USA) | |
| 10:00 | S1.2
S1.2
| Correlation between the BRAF V600E mutation; TGF beta pathway and tumour invasiveness in papillary thyroid carcinoma P. Santistebar, (Spain) | |
| 10:30 | S1.3
S1.3
| Molecular genotyping of papillary thyroid carcinoma M. Sobhrino-Simoes, (Portugal) | |
| 09:30 11:00 | Symposium 2: 40 years of male hormonal contraception research and no product Chairs: E. Nieschlag (Germany) & F. Wu (UK) | ||
| 09:30 | S2.1
S2.1
| Do we know enough about regulation of testicular function? R. McLachlan, (Australia) | |
| 10:00 | S2.2
S2.2
| Clinical trials in male hormonal contraception to date C. Meriggola, (Italy) | |
| 10:30 | S2.3
S2.3
| Acceptability of male hormonal contraception by the pharmaceutical industry and by the consumer F. Saad, (Germany) | |
| 09:30 11:00 | Symposium 3: Absolute fracture risk assessment with FRAX Chairs: F. Cetani (Italy) & TBC | ||
| 09:30 | S3.1
S3.1
| Overview of FRAX J. Kanis, (UK) | |
| 10:00 | S3.2
S3.2
| Use of FRAX in Asian populations L. Koh, (Singapore) | |
| 10:30 | S3.3
S3.3
| Beyond FRAX J. Eisman, (Australia) | |
| 09:30 11:00 | Symposium 4: The gut nutrient sensing in energy metabolism Chairs: H. Itoh (Japan) & C. Rotella (Italy) | ||
| 09:30 | S4.1
S4.1
| Bile acids and energy metabolism M. Watanbe, (Japan) | |
| 10:00 | S4.2
S4.2
| Taste receptors in gut regulate endocrine function R. Margolskee, (USA) | |
| 10:30 | S4.3
S4.3
| Gut microbiome and energy metabolism P. Cani, (Belgium) | |
| 09:30 11:00 | Symposium 5: Transition from paediatric to adult care - do we have progress? Chairs: C. Hoybye (Sweden) & P. Garofalo (Italy) | ||
| 09:30 | S5.1
S5.1
| Prader-Willi syndrome childhood and adult life: Outcome report from a consensus workshop C. Deal, (Canada) | |
| 10:00 | S5.2
S5.2
| Fertility options for young adults with panhypopituitarism M. Wierman, (USA) | |
| 10:30 | S5.3
S5.3
| Turner's syndrome: more than just looking after hormones G. Conway, (UK) | |
| 09:30 11:00 | Symposium 6: Subclinical adrenal diseases Chairs: A. Lacroix (Canada) & E. Husebye (Norway) | ||
| 09:30 | S6.1
S6.1
| Diagnosis of subclinical Cushing's syndrome: An update T. Yanase, (Japan) | |
| 10:00 | S6.2
S6.2
| Silent pheochromocytoma R. Clifton-Bligh, (Australia) | |
| 10:30 | S6.3
S6.3
| Subclinical adrenal insufficiency A. Falorni, (Italy) | |
| 09:30 11:00 | Symposium 7: Hormones, metabolism and cancer: more than coincidences? Chairs: J. Gromoll (Germany) & A. Dunaif (USA) | ||
| 09:30 | S7.1
S7.1
| Gene networks linking cancer metabolism and endocrine disease K. Struhl, (USA) | |
| 10:00 | S7.2
S7.2
| IGF system and cancer D. Le Roith, (USA) | |
| 10:30 | S7.3
S7.3
| Obesity and cancer A. Renehan, (UK) | |
| 09:30 11:00 | Symposium 8: Global phenotypes of endocrine disease | ||
| 09:30 | S8.1
S8.1
| Vitamin D deficiency in Asia G. El-hajj Fuleihan, (Lebanon) | |
| 10:00 | S8.2
S8.2
| Ethnic specific PCOS C. Wijeyaratne, (Sri Lanka) | |
| 10:30 | S8.3
S8.3
| Obesity and diabetes | |
| 09:30 11:00 | Symposium 9: The risk and benefits of tight glycaemic control Chairs: S. del Prato (Italy) & TBC | ||
| 09:30 | S9.1
S9.1
| What do type 2 diabetes outcome trials tell us about the cardiovascular risks and benefits of intensive glycaemic control H. Gerstein, (Canada) | |
| 10:00 | S9.2
S9.2
| Tight control of blood glucose levels in the hospitalised patient M. Korotkowsky, (USA) | |
| 10:30 | S9.3
S9.3
| Time course of the glucose legacy effect R.Holman, (UK) | |
| 11:00 11:30 | Coffee, Posters & Exhibition Exhibition Hall & Poster Hall | ||
| 11:30 12:30 | Debate 1: This house believes that metabolic (bariatric) surgery should be offered to every diabetic with a BMI over 30 For: F. Rubino (USA); Against: E. Mannucci (Italy) Chair: V. Pirags (Latvia) | ||
| 11:30 12:15 | Meet the Expert 1 | ||
| 11:30 | MTE1
MTE1
| Adrenal incidentalomas and subclinical Cushing's syndrome P. Stewart, (UK) | |
| 11:30 12:15 | Meet the Expert 2 | ||
| 11:30 | MTE2
MTE2
| Approach to the patient with Cushing's disease after pituitary surgery failure M. Toth, (Hungary) | |
| 11:30 12:15 | Meet the Expert 3 | ||
| 11:30 | MTE3
MTE3
| Osteoporosis in men U. Gruntmanis, (USA) | |
| 11:30 12:15 | Meet the Expert 4 | ||
| 11:30 | MTE4
MTE4
| Challenges of transsphenoidal pituitary surgery P. Cappabianca, (Italy) | |
| 11:30 12:15 | Meet the Expert 5 | ||
| 11:30 | MTE5
MTE5
| Difficult thyroid cancer cases L. Wartofsky, (USA) | |
| 11:30 12:15 | Meet the Expert 6 | ||
| 11:30 | MTE6
MTE6
| Clinical management of adrenocortical carcinoma M. Terzolo, (Italy) | |
| 11:30 12:15 | Meet the Expert 7 | ||
| 11:30 | MTE7
MTE7
| Pregnancy and pituitary disorders Z. Karaca, (Turkey) | |
| 11:30 12:15 | Meet the Expert 8 | ||
| 11:30 | MTE8
MTE8
| Diagnosis and treatment of precocious puberty L. Ghizzoni, (Italy) | |
| 12:25 13:10 | Meet the Expert 9 | ||
| 12:25 | MTE9
MTE9
| Diagnosis and treatment of SIADH C. Thompson, (Ireland) | |
| 12:25 13:10 | Meet the Expert 10 | ||
| 12:25 | MTE10
MTE10
| Elastosonography in the evaluation of thyroid and parathyroid lesions M. Erdogan, (Turkey) | |
| 12:25 13:10 | Meet the Expert 11 | ||
| 12:25 | MTE11
MTE11
| Diagnosis and treatment considerations in autoimmune polyendocrine syndrome O. Kampe, (Sweden) | |
| 12:25 13:10 | Meet the Expert 12 | ||
| 12:25 | MTE12
MTE12
| Goitre throughout the paediatric ages M. Polak, (France) | |
| 12:25 13:10 | Meet the Expert 13 | ||
| 12:25 | MTE13
MTE13
| Graves' ophthalmopathy W. Wiersinga, (The Netherlands) | |
| 12:25 13:10 | Meet the Expert 14 | ||
| 12:25 | MTE14
MTE14
| Hirsutism K. Unluhizarci, (Turkey) | |
| 12:25 13:10 | Meet the Expert 15 | ||
| 12:25 | MTE15
MTE15
| Pituitary tumours in adolescents and adults M. Andersen, (Denmark) | |
| 12:25 13:10 | Meet the Expert 16 | ||
| 12:25 | MTE16
MTE16
| Management of non-functioning pituitary adenomas N. Karavitaki, (UK) | |
| 12:30 13:15 | Lunch, Posters & Exhibition ESE President meets ESE Affiliated Society Presidents (invitation only) Exhibition Hall & Poster Hall | ||
| 13:15 14:45 | Symposium 10: Thyroid: From fetal life to adulthood Chairs: K. Brix (Germany) & S. Gullu (Turkey) | ||
| 13:15 | S10.1
S10.1
| Placental transport of thyroid hormone J. Franklyn, (UK) | |
| 13:45 | S10.2
S10.2
| Importance of fetal life for adult thyroid disease R. Gartner, (Germany) | |
| 14:15 | S10.3
S10.3
| Thyroid hormone and fetal neurological development M. Li , (Australia) | |
| 13:15 14:45 | Symposium 11: Novel genetic and endocrine insights in the Klinefelter's syndrome Chairs: K. Kula (Poland) & TBC | ||
| 13:15 | S11.1
S11.1
| Cognitive impairments in the XXY mouse model R. Swerdloff, (USA) | |
| 13:45 | S11.2
S11.2
| Endocrine changes in KS and the effects on growth, bone and body composition L. Aksglaede, (Denmark) | |
| 14:15 | S11.3
S11.3
| Epigenetic regulation of the supernumerary X chromosome and its escape genes J. Gromoll, (Germany) | |
| 13:15 14:45 | Symposium 12: Determinants of peak bone mass | ||
| 13:15 | S12.1
S12.1
| Epidemiology of peak bone mass in males K. Brixen, (Denmark) | |
| 13:45 | S12.2
S12.2
| The contribution of genetic factors W. van Hul, (Belgium) | |
| 14:15 | S12.3
S12.3
| Hormonal factors C. Ohlsson, (Sweden) | |
| 13:15 14:45 | Symposium 13: Novel therapies for protecting beta cell function at diagnosis of type 1 diabetes Chairs: I. Satman (Turkey) & TBC | ||
| 13:15 | S13.1
S13.1
| Therapy with anti-CD3 monoclonal antibody R. Buzzetti, (Italy) | |
| 13:45 | S13.2
S13.2
| Peptide therapy (Diapepe277) R. Itamar, (Israel) | |
| 14:15 | S13.3
S13.3
| Therapy with glutamic acid decarboxylase (GAD) J. Ludvigsson, (Sweden) | |
| 13:15 14:45 | Symposium 14: Wnt/Beta-catenin in pituitary development and disease Chairs: A. Spada (Italy) & G. Stalla (Germany) | ||
| 13:15 | S14.1
S14.1
| Wnt/Beta-catenin in pituitary development S. Camper, (USA) | |
| 13:45 | S14.2
S14.2
| Wnt/Beta-Catenin in craniopharyngioma J.P. Martinez-Barbera, (UK) | |
| 14:15 | S14.3
S14.3
| Wnt signalling in oestrogen induced lactotroph proliferation J. Davis, (UK) | |
| 13:15 14:45 | Symposium 15: Adrenal cancer Chairs: B. Skogseid (Sweden) & TBC) | ||
| 13:15 | S15.1
S15.1
| Molecular pathogenisi of adrenocortical cancer E. Lalli, (France) | |
| 13:45 | S15.2
S15.2
| Imaging in adrenocortical cancer I. Ilias, (Greece) | |
| 14:15 | S15.3
S15.3
| Genetics of micronodular hyperplasia C. Stratakis, (USA) | |
| 13:15 14:45 | Symposium 16: Understanding growth | ||
| 13:15 | S16.1
S16.1
| Understanding the genetic analyses of human height P. Visscher, (Australia) | |
| 13:45 | S16.2
S16.2
| Genes and the investigation of idiopathic short stature (ISS): are we ready for prime time? J-M Wit, (The Netherlands) | |
| 14:15 | S16.3
S16.3
| What is the optimal growth of small gestational age (SGA) babies: lessons from WHO S. Chernausek, (USA) | |
| 13:15 14:45 | Symposium 17: Hormonal control of pregnancy | ||
| 13:15 | S17.1
S17.1
| Hormone signalling between mother and foetus R. Reynolds, (UK) | |
| 13:45 | S17.2
S17.2
| What controls labour in humans? R. Smith, (Australia) | |
| 14:15 | S17.3
S17.3
| Placental hormones as putative markers of gestational diseases F. Petraglia, (Italy) | |
| 14:45 15:15 | Coffee, Posters & Exhibition Exhibition Hall & Poster Hall | ||
| 15:15 16:45 | Symposium 18: Molecular mechanisms in autoimmune thyroid disease | ||
| 15:15 | S18.1
S18.1
| Genetic markers - predictors of relapse of Graves' disease P-W. Wang, (Taiwan) | |
| 15:45 | S18.2
S18.2
| Genotype-phenotype correlations in GD T. Bednarczuk, (Poland) | |
| 16:15 | S18.3
S18.3
| Regulatory cells, Th17 lymphocytes, and dendritic cells in autoimmune thyroid disease M. Marazuela, (Spain) | |
| 15:15 16:45 | Symposium 19: Controversies in testosterone replacement Chairs: J-M. Kaufman (Belgium) & TBC | ||
| 15:15 | S19.1
S19.1
| Can we really measure testosterone? R.Legro, (USA) | |
| 15:45 | S19.2
S19.2
| Late onset hypogonadism - who should receive testosterone? J. Svartberg, (Norway) | |
| 16:15 | S19.3
S19.3
| Testosterone for women: why, when and how? S. Davis, (Australia) | |
| 15:15 16:45 | Symposium 20: Signalling to and from osteoclast | ||
| 15:15 | S20.1
S20.1
| Efferent signalling by osteoclasts K. Matsuo, (Japan) | |
| 15:45 | S20.2
S20.2
| Immune signalling in osteoclasts H. Takayanagi, (Japan) | |
| 16:15 | S20.3
S20.3
| TGF beta brings osteoclasts to sites of resorbtion X. Cao, (USA) | |
| 15:15 16:45 | Symposium 21: Obesity and reproduction Chairs: M. Tena-Sempere (Spain) & R. Pasquali (Italy) | ||
| 15:15 | S21.1
S21.1
| Integrating hypothalamic regulation of energy homeostasis and reproduction C. Elias, (USA) | |
| 15:45 | S21.2
S21.2
| Impact of obesity on male reproduction A.C. Martini, (Argentina) | |
| 16:15 | S21.3
S21.3
| Lifestyle modification and fertility R. Norman, (Australia) | |
| 15:15 16:45 | Symposium 22: Pituitary tumourigenesis Chairs: I. Huhtaniemi (UK) & TBC | ||
| 15:15 | S22.1
S22.1
| Molecular mechanisms: the genes involved S. Melmed, (USA) | |
| 15:45 | S22.2
S22.2
| AIP - tracing back a gene's influence (mechanism) M. Korbonits, (UK) | |
| 16:15 | S22.3
S22.3
| Pituitary tumorigenesis A. Daly, (Belgium) | |
| 15:15 16:45 | Symposium 23: Advances in regulation of aldosterone synthesis Chairs: H. Shibata (Japan) & F. Beuschlein (Germany) | ||
| 15:15 | S23.1
S23.1
| Regulation of CYP11B2 expression in H295R cells W. Rainey, (USA) | |
| 15:45 | S23.2
S23.2
| Extraadrenal aldosterone biosynthesis C. Gomez-Sanchez, (USA) | |
| 16:15 | S23.3
S23.3
| Role of N-type calcium channel blockers in aldosterone biosynthesis M. Yoshimura, (Japan) | |
| 15:15 16:45 | Symposium 24: Diabetes in children | ||
| 15:15 | S24.1
S24.1
| Epidemiology of ketoacidosis: Can we influence the incidence H. Bui, (Canada) | |
| 15:45 | S24.2
S24.2
| Hypotheses explaining the increase in type 1 diabetes M. Knip, (Finland) | |
| 16:15 | S24.3
S24.3
| Type 2 diabetes in children M. Craig, (Australia) | |
| 15:15 16:45 | Symposium 25: Reproductive hormone action | ||
| 15:15 | S25.1
S25.1
| GnRH receptor signalling U. Kaiser, (USA) | |
| 15:45 | S25.2
S25.2
| 3D models of LHR activation | |
| 16:15 | S25.3
S25.3
| Extragonadal FSH action - facts and dreams N. Ghinea, (France) | |
| 17:00 17:45 | Plenary Lecture 2 Chair: G. Forti (Italy) | ||
| 17:00 | PL2
PL2
| Testosterone - More than Sex M. Maggi, (Italy) | |
| 17:45 19:30 | Poster Reception Attended poster session, refreshments available Poster Hall | ||
| 18:30 20:00 | Industry Sponsored Satellite Symposia | ||
| 20:30 00:00 | ICE/ECE 2012 Congress Dinner Tickets should be purchased during registration Palazzo Corsini | ||
| 7 May 2012 | |||
| 07:00 20:00 | Registration | ||
| 07:00 08:30 | Industry Sponsored Satellite Symposia | ||
| 08:30 09:15 | Plenary Lecture 3 | ||
| 08:30 | PL3
PL3
| Mating, sex and the immune system in humans and fish M. Milinski, (Germany) | |
| 09:30 11:00 | Oral Communication Sessions | ||
| 09:30 11:00 | Endocrine Nurses' Session Further information about this session will follow shortly | ||
| Blank Abstract | |||
| 10:00 | The role of the Endocrine Nurse in puberty induction | ||
| 09:30 11:30 | ISE General Council Meeting (Invitation Only) | ||
| 09:30 11:00 | Puberty Induction and Sex Steroid Replacement in Young Adults | ||
| 09:30 | Puberty induction in males and females | ||
| 10:00 | The role of the Endocrine Nurse in puberty induction | ||
| 10:15 | Sex steroid replacement in young males and females | ||
| 10:45 | Choosing the right sex steroid replacement option for patients: the role of the Endocrine Nurse | ||
| 11:00 11:30 | Coffee, Posters & Exhibition Exhibition Hall & Poster Hall | ||
| 11:30 12:30 | Debate 2: This house believes that calcium supplementation causes heart attacks For: I. Reid (New Zealand); Against: C. Weaver (USA) Chair: J. Bollerslev (Norway) | ||
| 11:30 13:15 | ISE Travel Grant Reception (Invitation Only) | ||
| 11:30 12:15 | Meet the Expert 1 - Repeated | ||
| 11:30 | MTE1
MTE1
| Adrenal incidentalomas and subclinical Cushing's syndrome P. Stewart, (UK) | |
| 11:30 12:15 | Meet the Expert 2 - Repeated | ||
| 11:30 | MTE2
MTE2
| Approach to the patient with Cushing's disease after pituitary surgery failure M. Toth, (Hungary) | |
| 11:30 12:15 | Meet the Expert 3 - Repeated | ||
| 11:30 | MTE3
MTE3
| Osteoporosis in men U. Gruntmanis, (USA) | |
| 11:30 12:15 | Meet the Expert 4 - Repeated | ||
| 11:30 | MTE4
MTE4
| Challenges of transsphenoidal pituitary surgery P. Cappabianca, (Italy) | |
| 11:30 12:15 | Meet the Expert 5 - Repeated | ||
| MTE5
MTE5
| Difficult thyroid cancer cases L. Wartofsky, (USA) | ||
| 11:30 12:15 | Meet the Expert 6 - Repeated | ||
| 11:30 | MTE6
MTE6
| Clinical management of adrenocortical carcinoma M. Terzolo, (Italy) | |
| 11:30 12:15 | Meet the Expert 7 - Repeated | ||
| 11:30 | MTE7
MTE7
| Pregnancy and pituitary disorders Z. Karaca, (Turkey) | |
| 11:30 12:15 | Meet the Expert 8 - Repeated | ||
| 11:30 | MTE8
MTE8
| Diagnosis and treatment of precocious puberty L. Ghizzoni, (Italy) | |
| 12:25 13:10 | Meet the Expert 9 - Repeated | ||
| 12:25 | MTE9
MTE9
| Diagnosis and treatment of SIADH C. Thompson, (Ireland) | |
| 12:25 13:10 | Meet the Expert 10 - Repeated | ||
| 12:25 | MTE10
MTE10
| Elastosonography in the evaluation of thyroid and parathyroid lesions M. Erdogan, (Turkey) | |
| 12:25 13:10 | Meet the Expert 11 - Repeated | ||
| 12:25 | MTE11
MTE11
| Diagnosis and treatment considerations in autoimmune polyendocrine syndrome O. Kampe, (Sweden) | |
| 12:25 13:10 | Meet the Expert 12 - Repeated | ||
| 12:25 | MTE12
MTE12
| Goitre throughout the paediatric ages M. Polak, (France) | |
| 12:25 13:10 | Meet the Expert 13 - Repeated | ||
| 12:25 | MTE13
MTE13
| Graves' ophthalmopathy W. Wiersinga, (The Netherlands) | |
| 12:25 13:10 | Meet the Expert 14 - Repeated | ||
| 12:25 | MTE14
MTE14
| Hirsutism K. Unluhizarci, (Turkey) | |
| 12:25 13:10 | Meet the Expert 15 - Repeated | ||
| 12:25 | MTE15
MTE15
| Pituitary tumours in adolescents and adults M. Andersen, (Denmark) | |
| 12:25 13:10 | Meet the Expert 16 - Repeated | ||
| 12:25 | MTE16
MTE16
| Management of non-functioning pituitary adenomas N. Karavitaki, (UK) | |
| 12:30 13:15 | Lunch, Posters & Exhibition ESE President meets ESE New Members (invitation only) Exhibition Hall & Poster Hall | ||
| 13:15 14:45 | Symposium 26: TSH Receptor Chairs: R. Paschke (Germany) & TBC | ||
| 13:15 | S26.1
S26.1
| Low-molecular weight antagonists M. Gershengorn, (USA) | |
| 13:45 | S26.2
S26.2
| Epitope geography and intracellular pathways of TSH receptor antibodies T. Davis, (USA) | |
| 14:15 | S26.3
S26.3
| Structure and function of TSH receptor H. Biebermann, (USA) | |
| 13:15 14:45 | Symposium 27: Are endogenous testosterone levels predictors of cardiovascular events? Chairs: C. Wang (USA) & TBC | ||
| 13:15 | S27.1
S27.1
| Androgen action on the cardiovascular system K. Channer, (UK) | |
| 13:45 | S27.2
S27.2
| Endogenous androgens and cardiovascular risk in men D. Lee, (UK) | |
| 14:15 | S27.3
S27.3
| Endogenous androgens and cardiovascular risk women E. Barrett-Connor, (USA) | |
| 13:15 14:45 | Symposium 28: Osteoporosis treatment in 2012 and beyond Chairs: G. Borretta (Italy) & J. Stepan (Czech Republic) | ||
| 13:15 | S28.1
S28.1
| Controversial issues with bisphosphonates S. Papapoulos, (The Netherlands) | |
| 13:45 | S28.2
S28.2
| Sclerostin inhibition M. Robinson, (USA) | |
| 14:15 | S28.3
S28.3
| Other emerging therapies P. Ebeling, (Australia) | |
| 13:15 14:45 | Symposium 29: Are we ready for novel therapies in obesity? Chairs: F. Giorgino (Italy) & TBC | ||
| 13:15 | S29.1
S29.1
| Fibroblast growth factor 21: from pharmacology to physiology J. Spranger, (Germany) | |
| 13:45 | S29.2
S29.2
| Effects of GH administration on fat D. Clemmons, (USA) | |
| 14:15 | S29.3
S29.3
| GLP-1 and analogues in obesity A. Astrup, (Denmark) | |
| 13:15 14:45 | Symposium 30: New developments in pituitary adenomas Chairs: G. Raverot (France) & TBC | ||
| 13:15 | S30.1
S30.1
| Cytokines and other new genes in pituitary adenomas E. Arzt, (Argentina) | |
| 13:45 | S30.2
S30.2
| Dopastatin: an evolving story T. Brue, (France) | |
| 14:15 | S30.3
S30.3
| The use of temozolomide in pituitary tumours A. McCormack, (Australia) | |
| 13:15 14:45 | Symposium 31: Progress in treatment in primary aldosteronism Chairs: J. Widimsky (Czech Republic) & TBC | ||
| 13:15 | S31.1
S31.1
| Epidemiology and diagnosis of PA P-F Plouin , (France) | |
| 13:45 | S31.2
S31.2
| Surgery M. Walz, (Germany) | |
| 14:15 | S31.3
S31.3
| Medical treatment L. Sechi, (Italy) | |
| 13:15 14:45 | Symposium 32: Disorders of sex development (DSD) Chairs: T. Ogata (Japan) & P. Lee (USA) | ||
| 13:15 | S32.1
S32.1
| Genetics of DSD | |
| 13:45 | S32.2
S32.2
| Psychosocial and psychosexual outcome | |
| 14:15 | S32.3
S32.3
| Review of clinical guidelines F. Ahmed, (UK) | |
| 13:15 14:45 | Symposium 33: Pollution Related Acromegaly | ||
| 13:15 | S33.1
S33.1
| Pollution mediated acromegaly S. Cannavo, (Italy) | |
| 13:45 | S33.2
S33.2
| Exposure to endocrine disrupting chemicals may interfere with reproductive development in humans and affect timing of puberty K. Main, (Denmark) | |
| 14:15 | S33.3
S33.3
| Effect of iodine intake on thyroid disease in China | |
| 14:45 15:15 | Coffee, Posters & Exhibition Exhibition Hall & Poster Hall | ||
| 15:15 16:45 | Symposium 34: Effects of thyroid hormone derivatives | ||
| 15:15 | S34.1
S34.1
| Pathways of thyroid hormone metabolism J. Koehrle, (Germany) | |
| 15:45 | S34.2
S34.2
| Thyroid hormone mimetic compounds G. Chiellini, (Italy) | |
| 16:15 | S34.3
S34.3
| Trials of thyroid hormone analogues P. Ladenson, (USA) | |
| 15:15 16:45 | Symposium 35: Endocrinology and the Olympics: Will hormones help to win? Chairs: E. Ghigo (Italy) & TBC | ||
| 15:15 | S35.1
S35.1
| Does the high performance athlete need hormone replacement? L. Di Luigi, (Italy) | |
| 15:45 | S35.2
S35.2
| Can an endocrine patient participate in high performance sports? R. Auchus, (USA) | |
| 16:15 | S35.3
S35.3
| Hormone abuse in sports: the known and unknowns M. Thevis, (Germany) | |
| 15:15 16:45 | Symposium 36: Bone and metabolism | ||
| 15:15 | S36.1
S36.1
| Leptin and bone signalling S.Takeda, (Japan) | |
| 15:45 | S36.2
S36.2
| Insulin bone axis T. Clemens, (USA) | |
| 16:15 | S36.3
S36.3
| Osteocalcin as a messanger to multiple organs G. Karsenty, (USA) | |
| 15:15 16:45 | Symposium 37: Diabetes and cancer | ||
| 15:15 | S37.1
S37.1
| Epidemiological evidence for a link between diabetes and cancer R. Kaaks, (Germany) | |
| 15:45 | S37.2
S37.2
| The role of the insulin receptor in cancer A. Belfiore, (Italy) | |
| 16:15 | S37.3
S37.3
| Metformin and cancer risk | |
| 15:15 16:45 | Symposium 38: Craniopharyngioma: Hypothalamic complications Chairs: J. Hamilton (Canada) & TBC | ||
| 15:15 | S38.1
S38.1
| An overview of modern treatment of craniopharyngioma H. Müller, (Germany) | |
| 15:45 | S38.2
S38.2
| Hypothalamic disorders in craniopharyngioma; relevance to clinical practice C. Thompson, (Ireland) | |
| 16:15 | S38.3
S38.3
| Management of hypothalamic obesity G. Wittert, (Australia) | |
| 15:15 16:45 | Symposium 39: Adrenal insufficiency Chairs: W. Arlt (UK) & TBC | ||
| 15:15 | S39.1
S39.1
| Pathomechanism underlying adrenoleucodystrophy G. Raymond, (USA) | |
| 15:45 | S39.2
S39.2
| Molecular pathomechanisms of steroidogenetic adrenal disorders F. Riepe, (Germany) | |
| 16:15 | S39.3
S39.3
| New developments in the immunology of Addison's disease E. Husebye, (Norway) | |
| 15:15 16:45 | Symposium 40: New familial endocrine cancer syndromes: pathophysiology and counselling Chairs: A-P Gimenez-Roqueplo (France) & TBC | ||
| 15:15 | S40.1
S40.1
| Familial cancer syndromes in paediatrics: how do we counsel the families? W. Foulkes, (Canada) | |
| 15:45 | S40.2
S40.2
| The paediatric patient with paraganglioma syndrome M. Robledo, (Spain) | |
| 16:15 | S40.3
S40.3
| Li-Fraumeni syndrome diagnosed in paediatric patients D. Malkin, (Canada) | |
| 15:15 16:45 | Symposium 41: The endocrinology of adipose tissue Chairs: G. Fruhbeck (Spain) & TBC | ||
| 15:15 | S41.1
S41.1
| Brown or white: the ins and outs of adipocyte fate D. Richard, (Canada) | |
| 15:45 | S41.2
S41.2
| Obesity and insulin resistance: the cross-talk macrophage-adipocyte view J. Fernandez-Real, (Spain) | |
| 16:15 | S41.3
S41.3
| The fat cell: dynamics, genomics and adipokines P. Arner, (Sweden) | |
| 15:15 16:45 | Symposium 42: Novel insights into regulation of puberty Chairs: E. Malecka-Tendera (Poland) & M. Cappa (Italy) | ||
| 15:15 | S42.1
S42.1
| Central networks controlling the timing of puberty A. Lomniczi, (USA) | |
| 15:45 | S42.2
S42.2
| Re-wiring the hypothalamus with new peptides to control puberty V. Navarro, (USA) | |
| 16:15 | S42.3
S42.3
| Lessons from human genetics B.B. Mendonca, (Brazil) | |
| 16:35 17:10 | JOE / JME Prize | ||
| 17:10 17:55 | IPSEN Foundation Prize Lecture | ||
| 17:55 19:30 | Poster Reception Attended poster session, refreshments available Poster Hall | ||
| 18:30 20:00 | Industry Sponsored Satellite Symposia | ||
| 20:30 21:00 | ICE/ECE Congress Concert Tickets should be purchased during registration Basilica di San Lorenzo | ||
| 8 May 2012 | |||
| 07:00 20:00 | Registration | ||
| 07:00 08:30 | Industry Sponsored Satellite Symposia | ||
| 08:30 09:15 | Plenary Lecture 4 | ||
| 08:30 | PL4
PL4
| J. Hall, (USA) | |
| 09:30 11:00 | Oral Communication Sessions | ||
| 09:30 11:00 | Endocrine Nurses' Session Further information about this session will follow shortly | ||
| 09:30 11:00 | Cushing's and Prolactinoma - diagnosis and management | ||
| 09:30 | Diagnosis and Management of Cushing's syndrome | ||
| 10:00 | the role of the Endocrine Nurse in the diagnosis and management of the patient with Cushing's syndrome | ||
| 10:15 | Diagnosis and Management of Prolactinoma | ||
| 10:45 | The role of the Endocrine Nurse in the disgnosis and management of the patient with Prolactinoma | ||
| 11:00 11:30 | Coffee, Posters & Exhibition Exhibition Hall & Poster Hall | ||
| 11:30 12:30 | Debate 3: This house believes that PCOS needs a new name For: H. Teede (Australia); Against: D. Dewailly (France) Chair: A. Dunaif (USA) | ||
| 11:30 12:15 | Meet the Expert 17 | ||
| 11:30 | MTE17
MTE17
| Multiple endocrine neoplasia type II F. Raue, (Germany) | |
| 11:30 12:15 | Meet the Expert 18 | ||
| 11:30 | MTE18
MTE18
| Normocalcaemic hyperparathyroidism C. Marcocci, (Italy) | |
| 11:30 12:15 | Meet the Expert 19 | ||
| 11:30 | MTE19
MTE19
| Maturity onset diabetes of the young A. Hattersley, (UK) | |
| 11:30 12:15 | Meet the Expert 20 | ||
| 11:30 | MTE20
MTE20
| Diagnosis and treatment of secondary osteoporosis in children L. Ward, (USA) | |
| 11:30 12:15 | Meet the Expert 21 | ||
| 11:30 | MTE21
MTE21
| Autoimmune hyperthyroidism - initiation and duration of thionamide therapy P. Laurberg, (Denmark) | |
| 11:30 12:15 | Meet the Expert 22 | ||
| 11:30 | MTE22
MTE22
| Clinical management in transgender sex hormone treatment G. T'Sjoen, (Belgium) | |
| 11:30 12:15 | Meet the Expert 23 | ||
| 11:30 | MTE23
MTE23
| Subclinical hypothyroidism B. Biondi, (Italy) | |
| 11:30 12:15 | Meet the Expert 24 | ||
| 11:30 | MTE24
MTE24
| Approach to the management of the infertile couple A. Lenzi, (Italy) | |
| 11:30 | Blank Session | ||
| 12:25 13:10 | Meet the Expert 25 | ||
| 12:25 | MTE25
MTE25
| Pituitary incidentaloma S. Tsagarakis, (Greece) | |
| 12:25 13:10 | Meet the Expert 26 | ||
| 12:25 | MTE26
MTE26
| PCOS E. Diamanti-Kandarakis, (Greece) | |
| 12:25 13:10 | Meet the Expert 27 | ||
| 12:25 | MTE27
MTE27
| Differential diagnosis of Cushing's syndrome J. Salvador, (Spain) | |
| 12:25 13:10 | Meet the Expert 28 | ||
| 12:25 | MTE28
MTE28
| Hypoglycaemia and diabetes management W. Sheu, (Taiwan) | |
| 12:25 13:10 | Meet the Expert 29 | ||
| 12:25 | MTE29
MTE29
| Management of bone loss induced by cancer treatment J. Body, (Belgium) | |
| 12:25 13:10 | Meet the Expert 30 | ||
| 12:25 | MTE30
MTE30
| Treatment of vitamin D deficiency N. Tandon, (India) | |
| 12:25 13:10 | Meet the Expert 31 | ||
| 12:25 | MTE31
MTE31
| Cryptorchidism J. Toppari, (Finland) | |
| 12:25 13:10 | Meet the Expert 32 | ||
| 12:25 | MTE32
MTE32
| Management of GEP-NET tumours K. Oberg, (Sweden) | |
| 12:30 13:15 | Lunch, Posters & Exhibition Exhibition Hall & Poster Hall | ||
| 12:30 13:15 | ESE Annual General Meeting ESE Members Only - Lunch Provided | ||
| 13:15 14:45 | Symposium 43: Graves' orbitopathy (GO) Chairs: A. Karlsson (Sweden) & W. Wiersinga (The Netherlands) | ||
| 13:15 | S43.1
S43.1
| Immunopathogenesis of Graves' Orbitopathy R. Bahn, (USA) | |
| 13:45 | S43.2
S43.2
| How to restore euthyroidism in the presence of GO. Is there a best way? L. Hegedus, (Denmark) | |
| 14:15 | S43.3
S43.3
| Progress in immunosuppressive treatment of GO (selenium, steroid dosage, rituximab) L. Bartalena, (Italy) | |
| 13:15 14:45 | Symposium 44: Genome wide studies in reproduction Chairs: M. Urbanek (USA) & TBC | ||
| 13:15 | S44.1
S44.1
| Endometriosis K. Zondervan, (UK) | |
| 13:45 | S44.2
S44.2
| PCOS | |
| 14:15 | S44.3
S44.3
| Infertility J. Laven, (Netherlands) | |
| 13:15 14:45 | Symposium 45: Bone quallity and bone strength | ||
| 13:15 | S45.1
S45.1
| Bone quality and micro architecture R. Rizzoli, (Switzerland) | |
| 13:45 | S45.2
S45.2
| Fine element analysis P. Zysset, (Austria) | |
| 14:15 | S45.3
S45.3
| Non-invasive assessment of bone mass by various modalities R. Prince, (Australia) | |
| 13:15 14:45 | Symposium 46: Chronic inflammation and insulin resistance | ||
| 13:15 | S46.1
S46.1
| Macrophage derived apoptosis inhibitor expressed by macrophages (AIM) T. Miyazaki, (Japan) | |
| 13:45 | S46.2
S46.2
| Macrophage regulation of adipocyte biology P. Scherer, (USA) | |
| 14:15 | S46.3
S46.3
| The inflammatory-adipokine hypothesis and stem cell abnormalities R. Vettor, (Italy) | |
| 13:15 14:45 | Symposium 47: Cushing's syndrome Chairs: N. Shah (India) & TBC | ||
| 13:15 | S47.1
S47.1
| Long term sequelae of 'cured' Cushing's syndrome J. Newell-Price, (UK) | |
| 13:45 | S47.2
S47.2
| Established and new medical treatment options for Cushing's disease A. Tabarin, (France) | |
| 14:15 | S47.3
S47.3
| Learnings from ERCUSYN: The first 500 patients E. Valassi, (Spain) | |
| 13:15 14:45 | Symposium 48: Pathogenesis of primary aldosteronism Chairs: F. Mantero (Italy) & TBC | ||
| 13:15 | S48.1
S48.1
| Genomic profile in primary aldosteronism P. Hellman, (Sweden) | |
| 13:45 | S48.2
S48.2
| Transcriptomics in primary aldosteronism MC. Zennaro, (France) | |
| 14:15 | S48.3
S48.3
| Potassium channels in primary aldosteronism R. Warth, (Germany) | |
| 13:15 14:45 | Symposium 49: Genetic breakthroughs in reproductive pathology and physiology Chairs: J. Young (France) & TBC | ||
| 13:15 | S49.1
S49.1
| New mechanisms of hypothalamic amenorrhea N. Pitteloud, (Switzerland) | |
| 13:45 | S49.2
S49.2
| HAND2 - the gene of implantation I. Bagchi (USA), | |
| 14:15 | S49.3
S49.3
| RANK-ligand and breast cancer | |
| 13:15 14:45 | Symposium 50: Circadian regulation of metabolism Chairs: J. Klein (Germany) & TBC | ||
| 13:15 | S50.3
S50.3
| Circadian rhythms in adipose tissue J. Gimble, (USA) | |
| 13:45 | S50.1
S50.1
| Basic mechanisms of circadian regulation in the brain H. Oster, (Germany) | |
| 14:15 | S50.2
S50.2
| Metabolic dysfunction: impact of circadian and sleep regulation E. van Cauter, (USA) | |
| 13:15 14:45 | Symposium 51: Recent management of pheochromocytoma / paraganglioma syndrome Chair: M. Mannelli (Italy) ZP. Zeng (China) | ||
| 13:15 | S51.3
S51.3
| Treatment of malignant pheochromocytoma A. Tanabe, (Japan) | |
| 13:45 | S51.1
S51.1
| Recent progress in biochemical testing for pheochromocytoma S. Petersenn, (Germany) | |
| 14:15 | S51.2
S51.2
| Prevalence of SDH gene mutations in pheochromocytoma G. Opocher, (Italy) | |
| 14:45 15:15 | Coffee, Posters & Exhibition Exhibition Hall & Poster Hall | ||
| 15:15 16:45 | Symposium 52: Thyroid & Pregnancy Chairs: K. Poppe (Belgium) & TBC | ||
| 15:15 | S52.1
S52.1
| Outcome of the CATS study J. Lazarus, (UK) | |
| 15:45 | S52.2
S52.2
| The case for thyroid screen in pregnancy R. Negro, (Italy) | |
| 16:15 | S52.3
S52.3
| Which levels of TSH and/or TPO-Ab in pregnancy qualify for LT4 intervention? | |
| 15:15 16:45 | Symposium 53: Genetic polymorphism in reproduction Chairs: C. Krausz (Italy) & A. Latronico (Brazil) | ||
| 15:15 | S53.1
S53.1
| Genetic variation of the androgen receptor: from gene regulation to prostate cancer M. Zitzmann, (Germany) | |
| 15:45 | S53.2
S53.2
| Gene polymorphisms and male infertility S. Repping, (The Netherlands) | |
| 16:15 | S53.3
S53.3
| Genetic complexity of FSH reception function M. Simoni, (Italy) | |
| 15:15 16:45 | Symposium 54: Vitamin D Chairs: P. Lips (The Netherlands) & A. Mithal (India) | ||
| 15:15 | S54.1
S54.1
| Pleotrophic actions of vitamin D R. Bouillon, (Belgium) | |
| 15:45 | S54.2
S54.2
| Vitamin D and primary hyperparathyroidism L. Mosekilde, (Denmark) | |
| 16:15 | S54.3
S54.3
| Vitamin D and falls H. Bischoff-Ferrari, (USA) | |
| 15:15 16:45 | Symposium 55: The fatty liver as an endocrine disease Chairs: J. Tomlinson (UK) & TBC | ||
| 15:15 | S55.1
S55.1
| Pathogenesis of fatty liver disease C. Postic, (France) | |
| 15:45 | S55.2
S55.2
| Insulin sensitizer treatment of fatty liver disease K. Cusi, (USA) | |
| 16:15 | S55.3
S55.3
| Fatty liver disease in childhood V. Nobili, (Italy) | |
| 15:15 16:45 | Symposium 56: Pituitary development transcription factors: stem cells and beyond Chairs: M. Dattani (UK) & TBC | ||
| 15:15 | S56.1
S56.1
| THe GPS niche of stem cells in the pituitary C. Alvarez, (Spain) | |
| 15:45 | S56.2
S56.2
| LHX3: An insightful model of pituitary hormone deficiency S. Rhodes, (USA) | |
| 16:15 | S56.3
S56.3
| Pituitary cell fate determination by novel transcription factors J. Drouin, (Canada) | |
| 15:15 16:45 | Symposium 57: What's new in congenital adrenal hyperplasia (CAH)? | ||
| 15:15 | S57.1
S57.1
| Counselling from birth to the next generation N. Krone, (UK) | |
| 15:45 | S57.2
S57.2
| CAH and adulthood R. Ross, (UK) | |
| 16:15 | S57.3
S57.3
| Optimal replacement therapy N. Riesch, (Germany) | |
| 15:15 16:00 | Symposium 58: Best Clinical Practice | ||
| 15:15 | S58.1
S58.1
| Towards European guidelines for treatment of hyponaetrarmia B. Allolio, (Germany) | |
| 15:15 16:45 | Symposium 59: Obesity and thyroid function Chairs: C. Schalin-Jaentti (Finland) & E. Papini (Italy) | ||
| 15:15 | S59.1
S59.1
| Hyperthyrotropinemia and obesity in children T. Reinehr, (Germany) | |
| 15:45 | S59.2
S59.2
| Thyroid regulation of energy balance: the role of the hypothalamus A. Vidal-Puig, (UK) | |
| 16:15 | S59.3
S59.3
| DIO regulation in muscle A. Boelen, (The Netherlands) | |
| 15:15 16:45 | Symposium 60: Performance enhancing hormones in sports Chairs: M. Bildingmaier (Germany) & TBC | ||
| 15:15 | S60.1
S60.1
| The spectrum of hormones in sports doping F. Lanfranco, (Italy) | |
| 15:45 | S60.2
S60.2
| Growth hormone and testosterone - do they work? V. Birzniece, (Australia) | |
| 16:15 | S60.3
S60.3
| Erythropoietin and its derivatives M. Saugy, (Switzerland) | |
| 17:00 17:15 | ESE Young Investigators Awards & Poster Prizes Generously supported by Novartis | ||
| 17:15 18:00 | Plenary Lecture 5 | ||
| 17:15 | PL5
PL5
| Why your bones break - from childhood to old age E. Seeman, (Australia) | |
| 18:00 19:45 | Poster Reception Attended poster session, refreshments available | ||
| 18:30 20:00 | Industry Sponsored Satellite Symposia | ||
| 18:30 20:00 | Developing Endocrine Nursing across Europe | ||
| 18:30 | Developing a nurse-led service in Endocrinology | ||
| 18:50 | The role of Nurse Prescribing in the care of endocrine patients | ||
| 19:10 | Developing an International Endocrine Nurse network - open discussion | ||
| 19:20 | Poster display, networking and buffet meal | ||
| 20:30 23:00 | ESE President's Dinner (Invitation Only) | ||
| Blank Abstract | |||
| 9 May 2012 | |||
| 07:30 14:00 | Registration | ||
| 08:00 08:45 | Plenary Lecture 6 | ||
| 08:00 | PL6
PL6
| Maternal nutrition, metabolism and fetal programming C.S. Yajnik, (India) | |
| 09:00 10:30 | Symposium 61: New insights in thyroid cancer diagnosis Chairs: D. Fuehrer (Germany) & A. Lewinski (Poland) | ||
| 09:00 | S61.1
S61.1
| Mutant BRAF (T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status M. Zatelli, (Italy) | |
| 09:30 | S61.2
S61.2
| Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance M. Milas, (USA) | |
| 10:00 | S61.3
S61.3
| Does circulating thyroglobullin mRNA and protein levels predict early midterm thyroid cancer recurrence? A. Pontecorvi, (Italy) | |
| 09:00 10:30 | Symposium 62: Early Development and Treatment of PCOS Chairs: E. Diamanti-Kandarakis (Greece) & TBC | ||
| 09:00 | S62.1
S62.1
| Early hormone abnormalities in children of women with PCOS T. Sir-Petermann, (Chile) | |
| 10:00 | S62.3
S62.3
| Hyperandrogenism in obese girls - what is the significance? C. McCartney, (USA) | |
| 10:00 | S62.2
S62.2
| Precocious pubarche: is it a marker of PCOS? F. de Zegher, (Belgium) | |
| 09:00 10:30 | Symposium 63: Emerging ideas about phosphate metabolism Chairs: O. Ljungren (Sweden) & T. Sugimoto (Japan) | ||
| 09:00 | S63.1
S63.1
| Genetics of phosphate metabolism M. Econs, (USA) | |
| 09:30 | S63.2
S63.2
| FGF23: and tumour induced oestomalacia S. Fukumoto, (Japan) | |
| 10:00 | S63.3
S63.3
| FGF23 in renal disease J. Silver, (Israel) | |
| 09:00 10:30 | Symposium 64: Endoplasmic Reticulum Stress, Obesity and Metabolic Homeostasis Chairs: J. Castano (Spain) & TBC | ||
| 09:00 | S64.1
S64.1
| Autophagy in immunity and inflammation | |
| 09:30 | S64.2
S64.2
| Endoplasmic reticulum stress plays a central role in development of leptin resistance U. Ozcan, (USA) | |
| 10:00 | S64.3
S64.3
| P62, an autophagy hero or culprit? H. Stenmark, (Norway) | |
| 09:00 10:30 | Symposium 65: Somatostatin receptors in pituitary Chairs: AJ van der Lely (The Netherlands) & M. Gadelha (Brazil) | ||
| 09:00 | S65.1
S65.1
| Imaging somatostatin activity in live pituitary S. Schulz, (Germany) | |
| 09:30 | S65.2
S65.2
| Is somatostatin receptor expression in adenomas related to pharmacological response? S. Fougner, (Norway) | |
| 10:00 | S65.3
S65.3
| Somatostatiin receptors and filamin: a developing story C. Bousquet, (France) | |
| 09:00 10:30 | Symposium 66: HPA axis, stress metabolism and adaptation Chairs: M. Holmes (UK) & TBC | ||
| 09:00 | S66.1
S66.1
| Neuroendocrine and epigenetic impact on HPA function R. de Kloet, (The Netherlands) | |
| 09:30 | S66.2
S66.2
| HPA programming through perinatal epigenetic modifications M. Meaney, (Canada) | |
| 10:00 | S66.3
S66.3
| Modulation of cortisol action D. Ray, (UK) | |
| 09:00 10:30 | Symposium 67: Central regulation of energy homeostasis Chairs: C. Strasburger (Germany) & F. Casaneuva (Spain) | ||
| 09:00 | S67.1
S67.1
| CNS control of energy and glucose metabolism C. Koenner, (Germany) | |
| 09:30 | S67.2
S67.2
| Gut hormones: history, physiology and therapeutic opportunities R. Batterham, (UK) | |
| 10:00 | S67.3
S67.3
| Novel pharmacological approaches to treatment of diabetes and obesity M. Tschoep, (USA) | |
| 09:00 10:30 | Symposium 68: European network for the study of adrenal tumours (ENSAT) | ||
| 09:00 10:30 | Symposium 69: Current progress in the management of thyroid cancer Chairs: G. Brabant (Germany) & A. Gursoya (Turkey) | ||
| 09:00 | S69.1
S69.1
| TSH suppression: how low we should go D. Cooper, (USA) | |
| 09:30 | S69.2
S69.2
| rhTSH stimulated remnant ablation M. Schlumberger, (France) | |
| 10:00 | S69.3
S69.3
| Tyrosine kinase inhibitions in the management of progressing thyroid cancer S. Sherman, (USA) | |
| 09:00 10:30 | Symposium 70: Young Active Researchers Symposium (YAR) | ||
| 10:45 11:30 | Plenary Lecture 7 | ||
| 10:45 | PL7
PL7
| Diabetes as a gut disease M. Nauck, (Germany) | |
| 11:30 11:45 | Coffee, Posters & Exhibition Exhibition Hall & Poster Hall | ||
| 11:45 12:45 | Debate 4: This house believes that we do more harm than good in the treatment of thyroid low risk carcinoma For: I Hay (USA); Against: H. Dralle (Germany) Chair: M. Alevizaki (Greece) | ||
| 11:45 12:30 | Meet the Expert 17 - Repeated | ||
| 11:45 | MTE17
MTE17
| Multiple endocrine neoplasia type II F. Raue, (Germany) | |
| 11:45 12:30 | Meet the Expert 18 - Repeated | ||
| 11:45 | MTE18
MTE18
| Normocalcaemic hyperparathyroidism C. Marcocci, (Italy) | |
| 11:45 12:30 | Meet the Expert 19 - Repeated | ||
| 11:45 | MTE19
MTE19
| Maturity onset diabetes of the young A. Hattersley, (UK) | |
| 11:45 12:30 | Meet the Expert 20 - Repeated | ||
| 11:45 | MTE20
MTE20
| Diagnosis and treatment of secondary osteoporosis in children L. Ward, (USA) | |
| 11:45 12:30 | Meet the Expert 21 - Repeated | ||
| 11:45 | MTE21
MTE21
| Autoimmune hyperthyroidism - initiation and duration of thionamide therapy P. Laurberg, (Denmark) | |
| 11:45 12:30 | Meet the Expert 22 - Repeated | ||
| 11:45 | MTE22
MTE22
| Clinical management in transgender sex hormone treatment G. T'Sjoen, (Belgium) | |
| 11:45 12:30 | Meet the Expert 23 - Repeated | ||
| 11:45 | MTE23
MTE23
| Subclinical hypothyroidism B. Biondi, (Italy) | |
| 11:45 12:30 | Meet the Expert 24 - Repeated | ||
| 11:45 | MTE24
MTE24
| Approach to the management of the infertile couple A. Lenzi, (Italy) | |
| 12:45 13:30 | Meet the Expert 25 - Repeated | ||
| 12:45 | MTE25
MTE25
| Pituitary incidentaloma S. Tsagarakis, (Greece) | |
| 12:45 13:30 | Meet the Expert 26 - Repeated | ||
| 12:45 | MTE26
MTE26
| PCOS E. Diamanti-Kandarakis, (Greece) | |
| 12:45 13:30 | Meet the Expert 27 - Repeated | ||
| 12:45 | MTE27
MTE27
| Differential diagnosis of Cushing's disease J. Salvadore, (Spain) | |
| 12:45 13:30 | Meet the Expert 28 - Repeated | ||
| 12:45 | MTE28
MTE28
| Hypoglycaemia and diabetes management W. Sheu, (Taiwan) | |
| 12:45 13:30 | Meet the Expert 29 - Repeated | ||
| 12:45 | MTE29
MTE29
| Management of bone loss induced by cancer treatment J. Body, (Belgium) | |
| 12:45 13:30 | Meet the Expert 30 - Repeated | ||
| 12:45 | MTE30
MTE30
| Treatment of vitamin D deficiency N. Tandon, (India) | |
| 12:45 13:30 | Meet the Expert 31 - Repeated | ||
| 12:45 | MTE31
MTE31
| Cryptorchidism J. Toppari, (Finland) | |
| 12:45 13:30 | Meet the Expert 32 - Repeated | ||
| 12:45 | MTE32
MTE32
| Management of GEP-NET tumours K. Oberg, (Sweden) | |
| 13:40 14:25 | Plenary Lecture 8 | ||
| 13:40 | PL8
PL8
| Circadian clock genes and hypertension H. Okamura, (Japan) | |
| 14:25 14:30 | Farewell & Invitation to Copenhagen | ||
| 14:30 | Post Congress Courses / Post Congress Industry Sponsored Satellite Symposia | ||